Tremfya on The Journal.

The Journal.May 21, 2026

Barney Frank’s Legacy of Financial Reform

0:51
mid-roll
Kate Linebaugh, Ryan Knutson
The Wall Street Journal & Spotify Studios
May 21, 2026
UnknownBrand awarenessBaked-in adHealthcare
0:00 / 0:51
@ 13:58 in ep

Transcript

For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremfya offers self injection or intravenous infusion from the start. Tremfya is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks. If your doctor decides that you can self inject Tremfya, proper training is required. Tremfya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis. Serious allergic reactions, increased risk of infections or lower ability to fight them, and liver problems may occur. Before treatment, get checked for infections and tuberculosis. Tell your doctor if you have have an infection, flu like symptoms, or need a vaccine.

Auto-transcribed · verbatim audio matches · Report an error

More from this campaign

Tremfya: Prescription medicine for adults with moderately to severely active Crohn's… · Feb 22–Jul 12, 2026

4 promos

More from Tremfya

Recent reads from this sponsor outside this campaign

4 promos

Estimated ad cost

~$960range $180$6,600

Estimate of what a similar one-episode podcast ad would cost based on rank, placement, and duration

Methodology and limitations →
Part of campaign

Tremfya: Prescription medicine for adults with moderately to severely active Crohn's… · Feb 22–Jul 12, 2026

Tremfya is a prescription medicine for adults with moderately to severely active Crohn's disease or ulcerative colitis.

29 promos·11 shows

Episode

The Journal.
Barney Frank’s Legacy of Financial Reform
Hosts: Kate Linebaugh, Ryan Knutson
Publisher: The Wall Street Journal & Spotify Studios